When the microbiome helps the brain‐current evidence

Jovana Drljača,Nataša Milošević,Maja Milanović,Ludovico Abenavoli,Nataša Milić

DOI: https://doi.org/10.1111/cns.14076

2023-01-06

Abstract:Gut microbiota communicates with the brain in a bidirectionnal manner via n.vagus, microbial metabolites such as short chain fatty acids, cytokines, and neurochemicals.Gut microbiota dysbiosis has been implicated in pathophysiology of neurodegenerative diseases such as Alzheimer's and Parkinson's diseases, as well as of the psychiatric disorders like depression, schizophrenia and bipolar disorder. The gut microbiota‐brain axis has been recognized as a network of connections that provides communication between the gut microflora and both central and autonomic nervous system. The gut microbiota alteration has been targeted for therapy in various neurodegenerative and psychiatric disbalances. Psychobiotics are probiotics that contribute beneficially to the brain function and the host mental health as a result of an interaction with the commensal gut bacteria, although their mechanism of action has not been completely revealed. In this state‐of‐art review, the findings about the potential therapeutic effects of the psychobiotics alone or in combination with conventional medicine in the treatment of neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease, as well as in some psychiatric diseases like depression, schizophrenia, and bipolar disorder, have been summarized. The evidence of the psychobiotics therapeutic outcomes obtained in preclinical and clinical trials have been given respectively for the observed neurodegenerative and psychiatric disorders.

pharmacology & pharmacy,neurosciences